CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Inhibikase sells $50M of common stock to RA Capital

Neutral
AI Analysis

Summary

Inhibikase raised $50 million through the sale of common stock to RA Capital. This equity financing provides capital for the company's operations and development activities.

Importance:5/10
Sentiment:
0.00
equity offeringcapital raisefinancing
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on July 14, 2026 12:11 PM

Read Original